Mark Cornfeld
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Viral-associated cancers and disorders 4
- Polyomavirus and related diseases 3
- CAR-T cell therapy research 3
- Global Cancer Incidence and Screening 3
- Hematology top 10%
- Multiple Myeloma Research and Treatments 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Xiang QinMing QiPeter M. VoorheesHossein BorghaeiJessica VermeulenFrits van RheeLuis FayadSagar Lonial
- Cited by
- OncologyHematologyCancer Research
- Partner nations
- United StatesFranceItaly
In The Last Decade
Mark Cornfeld
31 papers receiving 829 citations
Peers
Comparison fields: 5 of 75
- Oncology 497
- Hematology 127
- Cancer Research 112
- Immunology 157
- Pathology and Forensic Medicine 122
Countries citing papers authored by Mark Cornfeld
This map shows the geographic impact of Mark Cornfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cornfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cornfeld more than expected).
Fields of papers citing papers by Mark Cornfeld
This network shows the impact of papers produced by Mark Cornfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cornfeld. The network helps show where Mark Cornfeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Cornfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 10 | |
| 5 | 2020 | 19 | |
| 6 | 2017 | 11 | |
| 7 | 2014 | 129 | |
| 8 | 2012 | 54 | |
| 9 | 2011 | 158 | |
| 10 | 2010 | 0 | |
| 11 | 2010 | 2 | |
| 12 | 2009 | 9 | |
| 13 | 2008 | 4 | |
| 14 | 2008 | 6 | |
| 15 | 2005 | 9 | |
| 16 | 2003 | 35 | |
| 17 | 2002 | 10 | |
| 18 | 2001 | 1 | |
| 19 | 2001 | 9 | |
| 20 | 1990 | 5 |
About Mark Cornfeld
Mark Cornfeld is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 838 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Multiple Myeloma Research and Treatments (4 papers), Viral-associated cancers and disorders (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Polyomavirus and related diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), CAR-T cell therapy research (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Oncology (497 citations), Hematology (127 citations), Cancer Research (112 citations), Immunology (157 citations) and Pathology and Forensic Medicine (122 citations). Mark Cornfeld has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Xiang Qin, Ming Qi, Peter M. Voorhees, Hossein Borghaei, Jessica Vermeulen, Frits van Rhee, Luis Fayad, Sagar Lonial, Lubomir Sokol and Karim Fizazi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.